Pharmaxi Polandsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-03-24
Share capital
5 000,00 PLN
Activity description

Pharmaxi Poland is a mid-sized contract research organization (CRO) that conducts phase II-IV clinical trials and late-phase non-interventional studies in Ukraine, Poland, and other European countries. The company offers services including study design, site management, medical writing, and data management, utilizing their proprietary EDC system OnlineCRF for efficient project oversight. Additionally, Pharmaxi collaborates with local vendors for specific tasks not covered in-house.

Registered address
ul. Korytnicka 46/52, 04-109 Warszawa, Poland
Website
pharmaxi.com.uaWebsite active
Email
Email inactive
Phone
Social media
Electronic delivery address
AE:PL-93766-73553-SJJHJ-28

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 152.29kMedianUSD 72.19kAverageUSD 3.22m
Net profit
This companyUSD 2.07kMedianUSD 113.00AverageUSD 112.32k
Operating costs
This companyUSD 139.49kMedianUSD 75.34kAverageUSD 3.02m
Assets
This companyUSD 140.30kMedianUSD 122.15kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2022-04-18. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Iryna Hoi — Attorney-in-fact (sole)
Yurii Lebid — President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Tetiana Lebid (45)
19$256.6219%
Yurii Lebid (45)
81$1,094.0081%

Yurii Lebid and Tetiana Lebid hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person
Yurii Lebid (45)

Competitors

Name
DigitmedS.A.
Medicofarma BiotechS.A.
SKIN Lab Internationalsp. z o.o.
Pharmacy Research Institutesp. z o.o.
CCTSsp. z o.o.
TCIsp. z o.o.
Dicellasp. z o.o.
Gcp-Service International Ltd. & Co. KgBranch (foreign co.)
Countess Laboratoriessp. z o.o.
New Valuesp. z o.o.

Change history

DateEvent
2025-02-05Address change
2022-03-24Entered in the register

FAQ

Last updated: 2026-07-06